198 related articles for article (PubMed ID: 16720667)
1. Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance.
Guarnieri V; Scillitani A; Muscarella LA; Battista C; Bonfitto N; Bisceglia M; Minisola S; Mascia ML; D'Agruma L; Cole DE
J Clin Endocrinol Metab; 2006 Aug; 91(8):2827-32. PubMed ID: 16720667
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
[TBL] [Abstract][Full Text] [Related]
3. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
4. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors.
Cetani F; Pardi E; Borsari S; Viacava P; Dipollina G; Cianferotti L; Ambrogini E; Gazzerro E; Colussi G; Berti P; Miccoli P; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5583-91. PubMed ID: 15531515
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of HRPT2 mutation screening to detect parathyroid carcinoma and atypical parathyroid adenoma of Thai patients.
Niramitmahapanya S; Sunthornthepvarakul T; Deerochanawong C; Sarinnapakorn V; Athipan P; Harnsomboonvana P; Kongsaengdao S
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S17-22. PubMed ID: 21717873
[TBL] [Abstract][Full Text] [Related]
6. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
8. [Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma].
Raue F; Haag Ch; Frank-Raue K
Dtsch Med Wochenschr; 2007 Jul; 132(27):1459-62. PubMed ID: 17583828
[TBL] [Abstract][Full Text] [Related]
9. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
[TBL] [Abstract][Full Text] [Related]
11. Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome.
Simonds WF; Robbins CM; Agarwal SK; Hendy GN; Carpten JD; Marx SJ
J Clin Endocrinol Metab; 2004 Jan; 89(1):96-102. PubMed ID: 14715834
[TBL] [Abstract][Full Text] [Related]
12. Re: Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
Guarnieri V; Bisceglia M; Bonfitto N; Cetani F; Marcocci C; Minisola S; Battista C; Chiodini I; Cole DE; Scillitani A
Surgery; 2008 Nov; 144(5):839-40. PubMed ID: 19081034
[No Abstract] [Full Text] [Related]
13. Hyperparathyroidism-jaw tumor syndrome: Results of operative management.
Mehta A; Patel D; Rosenberg A; Boufraqech M; Ellis RJ; Nilubol N; Quezado MM; Marx SJ; Simonds WF; Kebebew E
Surgery; 2014 Dec; 156(6):1315-24; discussion 1324-5. PubMed ID: 25444225
[TBL] [Abstract][Full Text] [Related]
14. Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism.
Howell VM; Cardinal JW; Richardson AL; Gimm O; Robinson BG; Marsh DJ
J Mol Diagn; 2006 Nov; 8(5):559-66. PubMed ID: 17065424
[TBL] [Abstract][Full Text] [Related]
15. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
Sarquis MS; Silveira LG; Pimenta FJ; Dias EP; Teh BT; Friedman E; Gomez RS; Tavares GC; Eng C; De Marco L
Surgery; 2008 May; 143(5):630-40. PubMed ID: 18436011
[TBL] [Abstract][Full Text] [Related]
16. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.
Carpten JD; Robbins CM; Villablanca A; Forsberg L; Presciuttini S; Bailey-Wilson J; Simonds WF; Gillanders EM; Kennedy AM; Chen JD; Agarwal SK; Sood R; Jones MP; Moses TY; Haven C; Petillo D; Leotlela PD; Harding B; Cameron D; Pannett AA; Höög A; Heath H; James-Newton LA; Robinson B; Zarbo RJ; Cavaco BM; Wassif W; Perrier ND; Rosen IB; Kristoffersson U; Turnpenny PD; Farnebo LO; Besser GM; Jackson CE; Morreau H; Trent JM; Thakker RV; Marx SJ; Teh BT; Larsson C; Hobbs MR
Nat Genet; 2002 Dec; 32(4):676-80. PubMed ID: 12434154
[TBL] [Abstract][Full Text] [Related]
17. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.
Bradley KJ; Cavaco BM; Bowl MR; Harding B; Cranston T; Fratter C; Besser GM; Conceição Pereira M; Davie MW; Dudley N; Leite V; Sadler GP; Seller A; Thakker RV
Clin Endocrinol (Oxf); 2006 Mar; 64(3):299-306. PubMed ID: 16487440
[TBL] [Abstract][Full Text] [Related]
18. HRPT2-related familial isolated hyperparathyroidism: could molecular studies direct the surgical approach?
Silveira LG; Dias EP; Marinho BC; Gomez RS; De Marco L; Sarquis MS
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1211-20. PubMed ID: 19169472
[TBL] [Abstract][Full Text] [Related]
19. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
[TBL] [Abstract][Full Text] [Related]
20. Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism.
Domingues R; Tomaz RA; Martins C; Nunes C; Bugalho MJ; Cavaco BM
Clin Endocrinol (Oxf); 2012 Jan; 76(1):33-8. PubMed ID: 21790700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]